Dentium CO., LTD (KRX:145720)

Market Cap	539.86B
Revenue (ttm)	401.91B
Net Income (ttm)	68.61B
Shares Out	8.62M
EPS (ttm)	7,955.64
PE Ratio	7.87
Forward PE	8.67
Dividend	600.00 (0.95%)
Ex-Dividend Date	Dec 27, 2024

Volume	25,319
Average Volume	45,462
Open	63,100
Previous Close	63,200
Day's Range	62,100 - 63,700
52-Week Range	54,000 - 112,400
Beta	0.89
RSI	43.21
Earnings Date	Aug 8, 2025

About Dentium CO., LTD

Dentium CO., LTD manufactures and sells dental medical instrument worldwide. Its implant systems include superline, implantium, implantium 2, N.R. line, simple line 2, and slim line. The company also provides block and coloring; regeneration products; and digital dentistry products. In addition, it offers orthodontics, bright resin, tooth care, and other dental products. The company was formerly known as Biostech Co., Ltd. and changed its name to Dentium Co.,Ltd. in August 2002. Dentium Co.,Ltd. was founded in 2000 and is headquartered in Seoul...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 800
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 145720

Financial Performance

In 2024, Dentium CO., LTD's revenue was 407.81 billion, an increase of 3.72% compared to the previous year's 393.19 billion. Earnings were 72.71 billion, a decrease of -24.67%.